TRGM — Targeted Medical Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.19m
- $5.26m
Annual balance sheet for Targeted Medical Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | C2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K/A | 10-Q | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.147 | 0.327 | 0.492 | 0.012 | 0.083 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.923 | 0.354 | 0.269 | 0.203 | 0.328 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.9 | 2.53 | 2.63 | 0.534 | 0.833 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.412 | 0.34 | 0.236 | 0.107 | 0.054 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 8.98 | 10.6 | 5 | 2.5 | 2.43 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.48 | 12.2 | 11.3 | 12.3 | 14.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 8.37 | 12.6 | 12 | 12.5 | 15.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.607 | -2 | -7.02 | -9.97 | -12.9 |
Total Liabilities & Shareholders' Equity | 8.98 | 10.6 | 5 | 2.5 | 2.43 |
Total Common Shares Outstanding |